ArticleFrontiers in medicine2024

PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling

Jiancheng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.